234 related articles for article (PubMed ID: 36417488)
21. Developments and current status of cell-free DNA in the early detection and management of hepatocellular carcinoma.
Du S; Cao K; Yan Y; Wang Y; Wang Z; Lin D
J Gastroenterol Hepatol; 2024 Feb; 39(2):231-244. PubMed ID: 37990622
[TBL] [Abstract][Full Text] [Related]
22. Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study.
Ng CKY; Di Costanzo GG; Tosti N; Paradiso V; Coto-Llerena M; Roscigno G; Perrina V; Quintavalle C; Boldanova T; Wieland S; Marino-Marsilia G; Lanzafame M; Quagliata L; Condorelli G; Matter MS; Tortora R; Heim MH; Terracciano LM; Piscuoglio S
Ann Oncol; 2018 May; 29(5):1286-1291. PubMed ID: 29509837
[TBL] [Abstract][Full Text] [Related]
23. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study.
Lewin J; Kottwitz D; Aoyama J; deVos T; Garces J; Hasinger O; Kasielke S; Knaust F; Rathi P; Rausch S; Weiss G; Zipprich A; Mena E; Fong TL
BMC Gastroenterol; 2021 Mar; 21(1):136. PubMed ID: 33765926
[TBL] [Abstract][Full Text] [Related]
24. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
[TBL] [Abstract][Full Text] [Related]
25. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma.
Xu RH; Wei W; Krawczyk M; Wang W; Luo H; Flagg K; Yi S; Shi W; Quan Q; Li K; Zheng L; Zhang H; Caughey BA; Zhao Q; Hou J; Zhang R; Xu Y; Cai H; Li G; Hou R; Zhong Z; Lin D; Fu X; Zhu J; Duan Y; Yu M; Ying B; Zhang W; Wang J; Zhang E; Zhang C; Li O; Guo R; Carter H; Zhu JK; Hao X; Zhang K
Nat Mater; 2017 Nov; 16(11):1155-1161. PubMed ID: 29035356
[TBL] [Abstract][Full Text] [Related]
27. Identification of DNA methylation signatures for hepatocellular carcinoma detection and microvascular invasion prediction.
Hao Y; Yang Q; He Q; Hu H; Weng Z; Su Z; Chen S; Peng S; Kuang M; Chen Z; Xu L
Eur J Med Res; 2022 Dec; 27(1):276. PubMed ID: 36464701
[TBL] [Abstract][Full Text] [Related]
28. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
29. Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma.
Phan TH; Chi Nguyen VT; Thi Pham TT; Nguyen VC; Ho TD; Quynh Pham TM; Tran TH; Nguyen TD; Khang Le ND; Nguyen TH; Duong ML; Bach HT; Kim VV; Pham TA; Nguyen BT; Vo Nguyen TN; Nguyen TD; Bieu Phu DT; Huu Phan BH; Nguyen DS; Truong DK; Do TT; Giang H; Nguyen HN; Phan MD; Tran LS
Future Oncol; 2022 Dec; 18(39):4399-4413. PubMed ID: 36786635
[TBL] [Abstract][Full Text] [Related]
30. Cell-free DNA testing for early hepatocellular carcinoma surveillance.
Chen L; Wu T; Fan R; Qian YS; Liu JF; Bai J; Zheng B; Liu XL; Zheng D; Du LT; Jiang GQ; Wang YC; Fan XT; Deng GH; Wang CY; Shen F; Hu HP; Zhang QZ; Ye YN; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Wang H; Kong F; Chen JM; Wen H; Wu BM; Wang CX; Wu L; Hou JL; Wang HY
EBioMedicine; 2024 Feb; 100():104962. PubMed ID: 38184937
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation markers in the detection of hepatocellular carcinoma.
Fu S; Debes JD; Boonstra A
Eur J Cancer; 2023 Sep; 191():112960. PubMed ID: 37473464
[TBL] [Abstract][Full Text] [Related]
33. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract][Full Text] [Related]
34. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
35. Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma.
Howell J; Atkinson SR; Pinato DJ; Knapp S; Ward C; Minisini R; Burlone ME; Leutner M; Pirisi M; Büttner R; Khan SA; Thursz M; Odenthal M; Sharma R
Eur J Cancer; 2019 Jul; 116():56-66. PubMed ID: 31173963
[TBL] [Abstract][Full Text] [Related]
36. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
Liu M; Zhang Z; Zhang W; Liu SM
WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
[TBL] [Abstract][Full Text] [Related]
37. Circulating Tumor DNA and Hepatocellular Carcinoma.
Yang JD; Liu MC; Kisiel JB
Semin Liver Dis; 2019 Nov; 39(4):452-462. PubMed ID: 31226727
[TBL] [Abstract][Full Text] [Related]
38. Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.
Elzehery R; Effat N; El Farahaty R; Elsayed Farag R; Abo-Hashem EM; Elhelaly R
Am J Clin Pathol; 2022 Aug; 158(2):254-262. PubMed ID: 35403666
[TBL] [Abstract][Full Text] [Related]
39. Liquid biopsies for hepatocellular carcinoma.
Su YH; Kim AK; Jain S
Transl Res; 2018 Nov; 201():84-97. PubMed ID: 30056068
[TBL] [Abstract][Full Text] [Related]
40. A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection.
Ning C; Cai P; Liu X; Li G; Bao P; Yan L; Ning M; Tang K; Luo Y; Guo H; Wang Y; Wang Z; Chen L; Lu ZJ; Yin J
EBioMedicine; 2023 Jul; 93():104645. PubMed ID: 37315449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
